Aziz Mottiwala - Mar 18, 2025 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: Chief Commercial Officer
Signature: /s/ Jeffrey Farrow, Attorney-in-Fact
Stock symbol: TARS
Transactions as of: Mar 18, 2025
Transactions value $: -$505,856
Form type: 4
Date filed: 3/20/2025, 09:49 PM
Previous filing: Mar 18, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Sale	-$169K	-3.64K	-4.82%	$46.29	72K	Mar 18, 2025	Direct	F1
transaction	TARS	Common Stock	Sale	-$169K	-3.56K	-4.94%	$47.40	68.4K	Mar 19, 2025	Direct	F1
transaction	TARS	Common Stock	Sale	-$169K	-3.37K	-4.92%	$50.11	65.1K	Mar 20, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Content

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.